In this week's episode of the Spine & Nerve podcast Dr. Nicolas Karvelas and Dr. Brian Joves discuss the recent DTM (Differential Targeted Multiplex) Spinal Cord Stimulation Randomized Controlled Trial with Dr. Michael Fishman. Dr. Fishman was one of the clinical investigators in this ground breaking study and joins our podcast to discuss the 12 month data and what it means for the future of neuromodulation and pain medicine.

The DTM clinical trial was birthed out of basic science research done by Dr. Ricardo Vallejo and his team at Stimgenics- research that we have had the opportunity to explore in depth previously. Please listen to the episode with Dr. Vallejo (https://anchor.fm/spine/episodes/More-glial-cells---Dr--Ricardo-Vallejo--science-that-matters--and-thinking-beyond-the-neuron-eb4m4i) for more details prior to exploring the clinical data.

The big take aways from this podcast (and the study):

1.  Profound and superior relief of low back pain at the primary end point (3 months) that was durable through 12 months

2. Real world data with patients recruited into the study that are a part of all of our practices (insurance based, long standing pain, etc.)

3. Science and pre- clinical research that leads and directs clinical trial and outcomes

Reference:

1. Fishman M, Cordner H, et al. DTM™ SCS RCT 12-month Data Results. Presented at a Medtronic webinar, jointly supported by the North American Neuromodulation Society (NANS), World Institute of Pain(WIP), and the American Society for Pain and Neuroscience (ASPN). October 19, 2020. Webinar available on society websites.

This podcast is for information and educational purposes only, it is not meant to be medical or career advice. If anything discussed may pertain to you, please seek council with your healthcare provider. The views expressed are those of the individuals expressing them, the may not represent the views of Spine & Nerve.

DISCLOSURE: Dr. Fishman and Dr. Joves are paid lecturers/educators for Medtronic

Dr. Fishman's bio:

Dr. Michael Fishman, MD is a double board-certified Anesthesiologist and Pain Medicine specialist. He graduated from Jefferson Medical College and went on to train in Anesthesiology at Yale University and in Pain Medicine at Stanford University.

Dr. Fishman has a particular interest in the use of spinal cord stimulation, peripheral nerve stimulation, and dorsal root ganglion (DRG) stimulation in the treatment of neuropathic pain. Dr. Fishman is actively involved with neuromodulation research and is on the cutting edge of new treatments for pain. He is actively involved in the North American Neuromodulation Society, where he serves as director of the Residents and Fellows Section and as course director for pre-conference workshops. In this capacity, he is at the helm of the largest neuromodulation training course in the world.